Several Appointments at Biomemory

Biomemory appointed Dominique Loque as chief scientific officer, alongside the addition of Chrystelle Roger, Steffen Hellmold, Olivier Lauvray, Thibault Vieille, and Raphaël Maunier to the advisory board.

These strategic appointments aim to drive growth and technological advancement by bringing in specialized knowledge and experience. This will enhance team capabilities, streamline processes, introduce innovative solutions, and open new avenues for R&D. Additionally, these appointments will strengthen connections with established industry players, helping navigate complexities, ensure adherence to industry standards, and leverage best practices to overcome significant barriers to entry and integration.

“In 10 years, we anticipate the addressable market for DNA data storage to be around $10 billion. It will be essential to collaborate with the largest players in the data storage sector to meet the growing demand for high-density storage in data centers while preserving our planet from excessive energy consumption,” says Erfane Arwani, CEO. “Our advisory board and the new CSO are instrumental in guiding us toward these ambitious goals, providing the expertise and connections necessary for Biomemory to thrive and lead in this innovative field.”

Dr. Dominique Loqué, PhD, who most recently led R&D at French biotech, Neoplants, Disease Control Biology at Bayer Cropsciences, and was director of Cell Wall Engineering at the Lawrence Berkeley National Laboratory for 10 years, will bring specialized innovation to Biomemory’s biotech team along with aiding in streamlining processes. This will allow scientific co-founders Drs. Stéphane Lemaire (current CSO) and Pierre Crozet, to focus on strategic innovation in DNA storage and molecular computing.

“As a discovery and technology lover, I am always eager to take on new challenges and develop solutions to address various problems. Joining Biomemory offers me the opportunity to tackle a global challenge in data storage, fulfill my admiration for the power of nature, and continue working on sustainability issues,” says Loqué. “I could not pass up the chance to join the Biomemory team as CSO, supporting the development and implementation of breakthrough technologies leveraged by the power of biology to provide sustainable, reliable, scalable, and long-term solutions for DNA storage and beyond.”

The newly appointed advisory board members will play a vital role in providing expert guidance in mitigating risks and accelerating the industrialization of Biomemory’s storage appliance. Including facilitating integration in data centers, miniaturization, and optimization of writing and reading speed. They will also foster engagement with technological partners, assist in securing funding for R&D, and ensure value delivery to clients.

Founding president of Myceco and biomimicry expert, Chrystelle Roger bridges research, public sectors, and industries to use biomimicry as a lever for sovereignty and sustainable innovation to mitigate ecological crises. She will help Biomemory develop strategies and ecosystems for public and private stakeholders, supporting the ecological transition.

“By supporting Biomemory’s board, I aim to promote bio-inspired technologies and structure sovereign programs with key actors like the French Ministry of Defense, Thales, and CNES. I believe this technology is crucial for French strategic autonomy and sustainable digital solutions,” she said.

With over 25 years of strategic executive experience in the semiconductor, memory, data storage, and life science industries, including his role as SVP at Twist Bioscience, Steffen Hellmold is a pioneer in DNA storage and co-founded the DNA Data Storage Alliance in 2020. He will be crucial in building relationships with the US market.

“Biomemory’s implementation approach to DNA storage is poised to ultimately enable Molecular Computational Storage. The launch of Biomemory’s DNA Card is a major milestone in engaging the ecosystem and commencing the lab-to-fab journey,” he said.

CEO of Optiboost, a service company that helps tech start-ups and mid-size companies reach their next inflection point, Olivier Lauvray has extensive experience in hardware, software, product launch, ecosystem building, and industrialization.

“Biomemory has a unique strategy and expertise to adapt its biotech IP to the Data Center environment. It can then leverage industry-available components to build cost-effective breakthrough DNA storage solutions. I believe this is the recipe for success and I am delighted to contribute to this adventure,” he said.

Founder of Acorus Networks (acquired by F5 Inc. for $500 million). Raphaël Maunier has 20 years of experience in network architecture, engineering, and design of edge innovation.

“My goal is to ensure robust, scalable, and resilient infrastructure that meets the demands of the data center environment while anticipating and mitigating potential challenges. I look forward to contributing to Biomemory’s mission to provide sustainable, cutting-edge storage technologies,” he said.

An expert in de-risking technologies and product development, Thibault  Vielleis the current VP engineering at French company, Depixus.

“The development of truly new technologies involves incredibly challenging journeys for those who take concepts from proof, to prototypes, and finally to finished products. As a huge fan of science, I am happy to help Biomemory identify the right battles at the right time, which is crucial for de-risking product development in the proper order,” he said.